Embecta Corp.EMBC

$3.11+0.02 (+0.65%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$183M
Micro-cap
-93%
2022 — today
10-Year Price
-93%
2022 — today
52-Week Range
$2.90$15.31
Current $3.11· 2%

Embecta Corp. is a medical technology enterprise devoted to enhancing the quality of life and health outcomes for individuals living with diabetes. Its comprehensive product portfolio includes essential tools such as pen needles, syringes, and advanced safety devices. Additionally, the company provides innovative digital applications designed to support patients in effectively managing their condition. Embecta distributes its offerings primarily through a network of wholesalers and distributors, reaching markets both domestically within the United States and across the globe. Established in 1924, Embecta's headquarters are located in Parsippany, New Jersey. The company transitioned to an independent entity from Becton, Dickinson and Company on April 1, 2022.

Valuation in context

P/E ratio
1.6
Near historic low
Near historic low — last 10 years
P/B ratio
-0.3
N/A
Not meaningful — company is unprofitable
EV / EBITDA
4.2
Near historic low
Near historic low — last 10 years
Dividend Yield
14.8%
Near historic high
Near historic highs — last 10 years
FCF Yield
111.7%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when EMBC is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.